Updated 13/09/2026
“Eat carrots for vitamin A” is dietary advice with a hidden dependency: carrots contain no vitamin A at all. They contain beta-carotene — a provitamin that only becomes retinol after an enzymatic conversion — and the efficiency of that conversion is one of the most genetically variable steps in human nutrition. For a substantial minority of the population, the carrot route quietly underdelivers, which is the scientific backdrop to every retinol-vs-carotene formulation decision.
The conversion step and its gatekeeper
Dietary beta-carotene is absorbed into intestinal cells, where the enzyme beta-carotene 15,15′-oxygenase (BCO1) cleaves the molecule centrally into two molecules of retinal, subsequently reduced to retinol — vitamin A proper. Even at its textbook best the route is inefficient: EU food regulation counts 6 µg of dietary beta-carotene as equivalent to 1 µg of retinol, an exchange rate reflecting incomplete absorption and partial conversion. And the system is deliberately throttled: BCO1 activity is feedback-regulated by retinoid status, down-shifting conversion when vitamin A stores are replete. That feedback is a superb safety feature — it is why beta-carotene cannot cause vitamin A toxicity and why it is the safe route in pregnancy (the teratogenicity explainer) — but it also means the provitamin route was never engineered for high-throughput delivery.
The genetics: conversion is not a constant
The decisive discovery of the genomic era is that BCO1 efficiency differs between people as a stable trait. Leung and colleagues (FASEB J, 2009) characterised two common single-nucleotide polymorphisms in BCO1 whose variant forms reduce the enzyme’s catalytic activity — carrying them lowered conversion efficiency by roughly 32–69% in functional testing, and the variant alleles are widespread: the study found nearly half of its European-ancestry cohort carrying at least one. Subsequent work synthesised by Lietz and colleagues (J Nutr, 2012) confirmed the picture and coined its practical vocabulary: a large fraction of adults are “low responders” to beta-carotene — feed them labelled carotene and their plasma retinyl ester response is a fraction of high-converters’, with additional variants in and beyond BCO1 stacking further variability. Conservatively, on the order of a quarter to nearly half of European-ancestry populations carry conversion-reducing genotypes. Almost no one knows their own status: BCO1 genotyping is not part of any routine panel. The nutritional consequence is plain — a carotene-only vitamin A strategy (typical of strict plant-based diets, and of “gentle” supplement formulas using only beta-carotene) delivers systematically less vitamin A to low converters, an invisible shortfall in exactly the nutrient whose status nobody routinely measures.
The preformed trade-off — reliability against the ceiling
Preformed retinol (retinyl palmitate) bypasses BCO1 entirely: absorbed, esterified, delivered — identical arithmetic in every genotype. That reliability is the entire case for using it in a supplement meant to guarantee coverage. But the bypass cuts both ways, and honesty requires the second half: skipping the feedback-controlled conversion also means skipping its safety valve, so every microgram of preformed retinol counts fully toward the tolerable upper intake level — the narrow corridor our 100%-NRV article maps (800 µg NRV vs 3,000 µg UL). Reliability without restraint would be a defect; the two design decisions are inseparable — preformed for genotype-independence, exactly 100% NRV for corridor discipline. One practical footnote completes the chemistry: retinyl palmitate is intensely fat-soluble, so an oil vehicle (the oil-drop format) is the chemically correct carrier, delivering the ester the way food fat would.
The clinical bottom line
Beta-carotene is vitamin A only after BCO1 says so — and for a genetically substantial minority (common variants cutting conversion by up to ~70%), BCO1 says it weakly. Preformed retinyl palmitate removes the genetic lottery at the price of counting fully against vitamin A’s narrow ceiling — which is precisely why the reliable form belongs at exactly 100% NRV and not a microgram more. Food carotenes remain the safe, self-limiting background; the supplement’s job is to make the guaranteed part genotype-proof.
Primary sources
- Leung WC, Hessel S, Méplan C, et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15′-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 2009;23(4):1041–1053. doi:10.1096/fj.08-121962
- Lietz G, Oxley A, Boesch-Saadatmandi C, Kobayashi D. Importance of β,β-carotene 15,15′-monooxygenase 1 (BCMO1) and β,β-carotene 9′,10′-dioxygenase 2 (BCDO2) in nutrition and health. J Nutr. 2012;142(1):161S–165S. doi:10.3945/jn.111.140756
- EFSA NDA Panel. Dietary Reference Values for vitamin A. EFSA Journal. 2015;13(3):4028. doi:10.2903/j.efsa.2015.4028
- von Lintig J. Provitamin A metabolism and functions in mammalian biology. Am J Clin Nutr. 2012;96(5):1234S–1244S. doi:10.3945/ajcn.112.034629
- Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191–201. doi:10.1093/ajcn/83.2.191
Educational information on nutrient genetics and function, not medical advice. Pregnancy-specific vitamin A rules are covered separately and take precedence.
🗺️ Find certified Georgian healthcare providers: sheniekimi.ge — Georgia Health Map · 998 clinics · 6,600+ doctors · 2,296 pharmacies
Was this article helpful?
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
